Define the Optimal Uptake Time of 68Ga-OPS202 When Used as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Newly Diagnosed Breast Cancer
Clinical trial NCT03697551 · TERMINATED
Trial details
- NCT number
- NCT03697551
- Sponsor
- Ipsen
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-22
- Primary completion
- 2019-02-06
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.